论文部分内容阅读
在奥地利心肌梗塞(MI)是重要的死亡原因,居民中每年急性心肌梗塞(AMI)的死亡率为150人/10万。对 MI 的治疗有两个目标:一是缩小急性期的的梗塞范围,二是防止复发。各种治疗方法都应当围绕这两个目标。首先复习一下β-阻滞剂在MI治疗中的地位: β-阻滞剂对冠心病治疗产生正效应的病理生理基础: 通常冠心病患者的心外膜冠状动脉发生
Myocardial infarction (MI) in Austria is an important cause of death, with a yearly mortality rate of 150 people / 100,000 for acute myocardial infarction (AMI). The treatment of MI has two goals: First, reduce the scope of acute infarction, the second is to prevent recurrence. A variety of treatment methods should focus on these two goals. First review the role of β-blockers in the treatment of MI: The Pathophysiological Basis for the Positive Effects of β-blockers on Coronary Heart Disease: The Epicardial Coronary Artery Is Generally Occurred in Patients with Coronary Heart Disease